Limb-girdle muscular dystrophy type 1A (LGMD 1A) is a genetic disorder belonging to the group of myodystrophies. It is characterized by progressive muscle weakness and atrophy, primarily affecting proximal muscle groups, such as the shoulder girdle and pelvic girdle muscles. This disease is characterized by early onset and often rapid progression, which significantly worsens the quality of life of patients. Difficulties with physical activity are observed, which leads to the need for additional help and support from others. The etiopathogenesis of the disease is associated with a violation of the structure and function of muscle fibers, which is caused by mutations in the gene encoding certain proteins important for maintaining the integrity of muscle tissue.
History of the disease and interesting historical facts
The first complete description of limb-girdle muscular dystrophy was proposed in the early 20th century. The disease was initially described by doctors observing patients with progressive muscle weakness of various forms and clinical manifestations. The most interesting fact is that for a long time the mechanism of inheritance of the waist and the cause of the disease remained unclear until genetic aspects associated with mutations in certain genes were discovered. Interest in these muscular dystrophies increased in 1987, when the first gene associated with this pathology was discovered - DMD.
Epidemiology
Epidemiological data show that limb-girdle muscular dystrophy type 1A occurs in the population with a frequency of 1:100,000. The age of onset of the disease is usually 20-30 years, although the first symptoms may appear earlier. It is known that the detection of the disease may vary depending on the geographic region and ethnicity of the population. For example, in some populations, cases of mutation may be more frequent, while in other regions the incidence is lower.
Genetic predisposition to this disease
The main cause of limb-girdle muscular dystrophy type 1A is mutations in the gene responsible for the synthesis of dystrophin, which plays a key role in the structural support of muscle cells. These mutations can be different - from point changes to more significant deletions. In most cases, the disease is inherited in a recessive manner, which makes carriers of genetic changes healthy, but they can pass the disease on to their offspring. There is also a sporadic form of the disease, when new mutations occur in the genomes.
Risk factors for the development of this disease
Risk factors for the disease include:
- Heredity - the presence of relatives with similar diseases.
- Gender - Males are at higher risk.
- Certain ethnic groups (hereditary factors may be more common in some populations).
- Environmental factors and exposure to toxic substances can negatively impact muscle health.
Diagnosis of this disease
Diagnosis of limb-girdle muscular dystrophy type 1A includes several stages.
- Main symptoms: muscle weakness, atrophy, loss of coordination, problems with movement.
- Laboratory tests: a blood test to assess levels of creatine kinase, which is usually elevated in muscular dystrophies.
- Radiological examinations: Magnetic resonance imaging (MRI) to detect changes in muscle tissue.
- Other types of disease diagnostics: electromyography to study the electrical activity of muscles.
- Differential diagnosis: Other causes of muscle weakness, such as myasthenia gravis, polymyositis, and Werdnig-Goreff disease, must be excluded.
Treatment
Treatment of limb-girdle muscular dystrophy type 1A has its own characteristics and may include:
- General treatment: physical therapy and rehabilitation measures to maintain muscle function.
- Pharmacological treatment: anti-inflammatory drugs and corticosteroids to reduce inflammation.
- Surgical treatment: surgical interventions to correct deformities and improve quality of life.
- Other types of treatment: the use of assistive devices such as prostheses and orthoses to improve mobility.
List of medications used to treat this disease
The following drugs are used in the treatment of limb-girdle muscular dystrophy:
- Corticosteroids (prednisolone, methylprednisolone);
- Immunosuppressants (azathioprine).
- Functional supplements (such as creatine).
- Combinations of anti-inflammatory drugs.
Disease monitoring
Monitoring of the patient's condition with limb-girdle muscular dystrophy is carried out on a regular basis. Includes:
- Check-ups: Regular check-ups are required to assess the progression of any symptoms.
- Forecast: depends on the individual characteristics of the patient and the start of treatment.
- Complications: may include loss of mobility, development of musculoskeletal disorders and problems with respiratory function.
Age-related features of the disease
Limb-girdle muscular dystrophy type 1A can present differently depending on the age group:
- Children and teenagers: more pronounced clinical symptoms, rapid progression of the disease.
- Adults: a slower rate of progression and the appearance of complex symptoms with age is possible.
Questions and Answers
- What are the first signs of the disease? Early signs may include muscle weakness, especially in the shoulders and hips, difficulty lifting, and problems with balance.
- How is limb-girdle muscular dystrophy diagnosed? Diagnosis includes blood tests, MRI, electromyography and assessment of the patient's symptoms.
- Can this disease be cured? There is no complete cure, but progression can be slowed with the help of complex therapy and rehabilitation measures.
- What is the life expectancy of patients with this dystrophy? Life expectancy may vary, but timely treatment and rehabilitation can help and support the patient.
- What are the main ways of caring for patients with this disease? These include regular physical activity, dietary control, and the use of assistive devices in daily living.
Advice from Dr. Oleg Korzhikov
Dr. Oleg Korzhikov recommends: “For those who are faced with limb-girdle muscular dystrophy type 1A, it is important to monitor their condition and maintain an active lifestyle to the extent possible. Regular physical training will help maintain muscle function. It is also worth seeking support from doctors, participating in rehabilitation programs and not being embarrassed to ask for help from loved ones. Each case is individual, and it is important to find the optimal approach to treatment and symptom management.”
